Recanalization of Acute Intracranial Artery Occlusion Using Temporary Endovascular Bypass Technique.
10.5469/neuroint.2013.8.2.80
- Author:
Sang Hyun SUH
1
;
Kyung Yul LEE
;
Kwon Duk SEO
;
Soo Mee LIM
;
Hong Gee ROH
;
Byung Moon KIM
Author Information
1. Department of Radiology, Gangnam Severance Hospital, Yonsei University, Seoul, Korea. suhsh11@yuhs.ac
- Publication Type:Original Article
- Keywords:
Stroke;
Recanalization;
Temporary endovascular bypass;
Retrievable stent
- MeSH:
Angiography;
Arteries;
Basilar Artery;
Cerebral Infarction;
Female;
Glycosaminoglycans;
Humans;
Infusions, Intra-Arterial;
Intracranial Hemorrhages;
Mechanical Thrombolysis;
Middle Cerebral Artery;
Retrospective Studies;
Stents;
Stroke;
Tissue Plasminogen Activator;
Tyrosine;
Urokinase-Type Plasminogen Activator
- From:Neurointervention
2013;8(2):80-86
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: The purpose of this study is to present our preliminary experience of the temporary endovascular bypass (TEB) technique using an Enterprise stent for recanalization of acute intracranial artery (IA) occlusion. MATERIALS AND METHODS: Patients treated by TEB were enrolled in this retrospective study from January 2009 to May 2010. All the procedures consist of temporary partial deployment and subsequent retrieval of Enterprise stent, supplemented by intra-arterial infusion of urokinase (UK) and/or tirofiban. According to the thrombolysis in cerebral infarction (TICI) classification, recanalization was evaluated with initial and postprocedural angiography. Safety was evaluated related to the procedure and clinical outcomes were assessed by National Institute of Health Stroke Scale (NIHSS) score at discharge and modified Rankin scale (mRS) score at 3 months. RESULTS: Eleven patients (median NIHSS 12.8, mean age 61.6 years, male: female = 8:3) with acute IA occlusion were treated with TEB. All the patients presented with TICI 0, and the occluded vessel was the middle cerebral artery (n=7), the basilar artery (n=1), and the distal ICA occlusion (n = 3). IV infusion of tissue plasminogen activator (tPA) was done in 4 patients and mechanical thrombolysis with intra-arterial UK was performed in 9. Recanalization was achieved in 73% (8 patients; TICI > or = 2). There were no procedure-related complications except for two asymptomatic intracranial hemorrhages. Improvement (> or = 4 points on the NIHSS) and good outcome (mRS < or =2) after 90 days was shown in six patients (55%). One patient died 6 days after procedure. CONCLUSION: TEB may be a valuable treatment option in acute thromboembolic IA occlusion without stent implantation.
